Get App Open
In App
Lending
Lending
Open App
you are here:

Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE03Q201024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 05, 16:01
927.00 -2.40 (-0.26%)
Volume
AVERAGE VOLUME
5-Day
26,938
10-Day
18,104
30-Day
22,947
2,889
  • Prev. Close

    929.40

  • Open Price

    945.45

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 05, 15:59
923.00 -6.10 (-0.66%)
Volume
AVERAGE VOLUME
5-Day
143,667
10-Day
143,124
30-Day
273,579
28,385
  • Prev. Close

    929.10

  • Open Price

    931.50

  • Bid Price (Qty.)

    923.00 (3)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Balance Sheet of Alivus Life Sciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 24.51 24.51 24.51 24.51 1.96  
Total Share Capital 24.51 24.51 24.51 24.51 1.96  
Reserves and Surplus 2,792.87 2,307.82 2,107.02 2,026.31 750.79  
Total Reserves and Surplus 2,792.87 2,307.82 2,107.02 2,026.31 750.79  
Total Shareholders Funds 2,817.37 2,332.32 2,138.21 2,054.31 752.75  
NON-CURRENT LIABILITIES  
Long Term Borrowings 0.00 0.00 0.00 0.00 0.00  
Deferred Tax Liabilities [Net] 54.43 48.79 42.43 31.50 22.89  
Other Long Term Liabilities 50.96 14.76 17.09 1.20 0.00  
Long Term Provisions 18.54 15.77 0.00 0.00 0.00  
Total Non-Current Liabilities 123.92 79.32 59.53 32.70 22.89  
CURRENT LIABILITIES  
Short Term Borrowings 0.00 0.00 0.00 0.00 0.00  
Trade Payables 390.46 368.66 396.56 307.72 221.31  
Other Current Liabilities 62.74 58.08 92.32 61.84 980.23  
Short Term Provisions 16.96 12.03 15.54 14.44 19.90  
Total Current Liabilities 470.16 438.77 504.41 384.00 1,221.44  
Total Capital And Liabilities 3,411.45 2,850.41 2,702.15 2,471.01 1,997.08  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 942.67 795.01 774.89 584.65 564.89  
Intangible Assets 12.28 10.05 5.74 10.38 7.91  
Capital Work-In-Progress 94.25 101.19 49.35 91.69 14.10  
Other Assets 0.00 0.00 0.00 0.00 0.00  
Fixed Assets 1,056.86 911.05 842.25 686.72 586.90  
Non-Current Investments 0.08 0.08 0.08 0.08 0.08  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 0.00 0.00 0.00 0.00 0.00  
Other Non-Current Assets 19.36 23.29 9.49 19.63 11.06  
Total Non-Current Assets 1,076.30 934.41 851.81 706.42 598.03  
CURRENT ASSETS  
Current Investments 477.62 0.00 0.00 0.00 0.00  
Inventories 673.95 666.59 604.17 516.24 513.42  
Trade Receivables 969.74 765.43 806.77 673.49 619.50  
Cash And Cash Equivalents 71.24 301.59 309.40 512.16 115.60  
Short Term Loans And Advances 0.00 0.00 0.00 0.00 0.00  
OtherCurrentAssets 142.62 182.38 130.01 62.69 150.52  
Total Current Assets 2,335.16 1,916.00 1,850.34 1,764.58 1,399.04  
Total Assets 3,411.45 2,850.41 2,702.15 2,471.01 1,997.08  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 37.92 34.20 12.83 50.42 17.23  
CIF VALUE OF IMPORTS  
Raw Materials 0.00 0.00 0.00 0.00 0.00  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 0.00 0.00 0.00 0.00 0.00  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 491.59 468.18 500.12 1,056.78 787.01  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- -- -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods -- -- -- -- --  
Other Earnings 1,152.18 1,035.14 969.07 388.26 395.51  
BONUS DETAILS  
Bonus Equity Share Capital 19.60 19.60 19.60 19.60 --  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- -- -- -- --  
Non-Current Investments Unquoted Book Value 0.08 0.08 0.08 0.08 0.08  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- -- -- -- --  
Current Investments Unquoted Book Value 477.62 -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970